{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:01:31Z","timestamp":1756382491744,"version":"3.44.0"},"reference-count":11,"publisher":"BMJ","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DTB"],"published-print":{"date-parts":[[1997,7]]},"abstract":"<jats:p>\u25bcAnastrozole (Arimidex - Zeneca) and \u25bcletrozole (Femara - Novartis) are the first selective, oral, non-steroidal aromatase inhibitors. They are licensed for the treatment of advanced breast cancer in postmenopausal women where tamoxifen or other anti-oestrogen therapy has failed. The manufacturers of both drugs claim that their products are more effective, less toxic and better tolerated than the progestogen megestrol acetate, the standard therapy in this clinical situation. We assess these claims.<\/jats:p>","DOI":"10.1136\/dtb.1997.35755","type":"journal-article","created":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T16:15:40Z","timestamp":1216397740000},"page":"55-56","source":"Crossref","is-referenced-by-count":5,"title":["New aromatase inhibitors for breast cancer"],"prefix":"10.1136","volume":"35","member":"239","published-online":{"date-parts":[[1997,7,1]]},"reference":[{"key":"2025082701041893000_35.7.55.1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2165\/00003495-199345010-00007","article-title":"Formestane: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the management of breast cancer and prostatic cancer","volume":"45","author":"Wiseman","year":"1993","journal-title":"Drugs"},{"key":"2025082701041893000_35.7.55.2","unstructured":"Miller WR . The clinical relevance of aromatase activity in breast tumour tissue Jonat W Santen RJ . Aromatase inhibition: present and future Carnforth: Parthenon Publishing Group 1991."},{"key":"2025082701041893000_35.7.55.3","unstructured":"\u25bcAnastrozole. Summary of product characteristics UK: Zeneca Limited May 1996."},{"key":"2025082701041893000_35.7.55.4","unstructured":"\u25bcLetrozole. Summary of product characteristics UK: Ciba Pharmaceuticals November 1996."},{"key":"2025082701041893000_35.7.55.5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/bjc.1996.94","article-title":"Arimidex (ZD1033): a selective, potent inhibitor of aromatase in post-menopausal female volunteers","volume":"73","author":"Yates","year":"1996","journal-title":"Br J Cancer"},{"key":"2025082701041893000_35.7.55.6","first-page":"324","article-title":"Phase I study of the oral nonsteroidal aromatase inhibitor CGS 20267 in healthy postmenopausal women","volume":"77","author":"Iveson","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2025082701041893000_35.7.55.7","doi-asserted-by":"publisher","DOI":"10.1210\/jc.77.2.324"},{"key":"2025082701041893000_35.7.55.8","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(95)00014-3"},{"key":"2025082701041893000_35.7.55.9","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970215)79:4<730::AID-CNCR10>3.0.CO;2-0"},{"key":"2025082701041893000_35.7.55.10","doi-asserted-by":"crossref","first-page":"49 [abstract]","DOI":"10.1016\/0959-8049(96)84236-5","article-title":"Double-blind trial in postmenopausal (PMP) women with advanced breast cancer (ABC) showing a dose-effect and superiority of 2.5mg letrozole over megestrol acetate (MA)","volume":"32","author":"Smith","year":"1996","journal-title":"Eur J Can"},{"key":"2025082701041893000_35.7.55.11","first-page":"156a [abstract]","article-title":"Letrozole, a new potent, selective aromatase inhibitor (AI) superior to aminoglutethimide (AG) in postmenopausal women with advanced breast cancer (ABC) previously treated with antiestrogens","volume":"16","author":"Marty","year":"1997","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Drug and Therapeutics Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/dtb.1997.35755","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:04:29Z","timestamp":1756281869000},"score":1,"resource":{"primary":{"URL":"https:\/\/dtb.bmj.com\/lookup\/doi\/10.1136\/dtb.1997.35755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,7]]},"references-count":11,"journal-issue":{"issue":"7","published-online":{"date-parts":[[1997,7,1]]},"published-print":{"date-parts":[[1997,7]]}},"alternative-id":["10.1136\/dtb.1997.35755"],"URL":"https:\/\/doi.org\/10.1136\/dtb.1997.35755","relation":{},"ISSN":["0012-6543","1755-5248"],"issn-type":[{"type":"print","value":"0012-6543"},{"type":"electronic","value":"1755-5248"}],"subject":[],"published":{"date-parts":[[1997,7]]}}}